A client presents with fever, foul-smelling vaginal discharge, and tachycardia after a miscarriage. What is the priority concern?

Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit the enzyme cyclooxygenase, which is responsible for the synthesis of prostaglandins. Primary dysmenorrhea is caused by an excess of prostaglandin F2-alpha, which triggers intense uterine contractions and ischemia. Reducing these levels effectively alleviates menstrual cramping and associated systemic symptoms.

A. Antidepressants: While SSRIs are used for the emotional symptoms of premenstrual dysphoric disorder, they are not the first-line treatment for the physical pain of dysmenorrhea. They do not inhibit the uterine prostaglandins that cause the primary cramping. They address neurological rather than myometrial targets.

B. Insulin: Insulin is used to manage diabetes mellitus and has no clinical role in the treatment of menstrual pain. It does not affect uterine contractility or prostaglandin levels. Administering it to a non-diabetic client would cause life-threatening hypoglycemia.

C. Antibiotics: These agents treat infections like pelvic inflammatory disease, which can cause secondary dysmenorrhea. However, they are not used for the symptomatic relief of standard menstrual cramps. Antibiotics do not have analgesic or anti-inflammatory properties for non-infectious pelvic pain.

D. NSAIDS: Drugs like ibuprofen and naproxen are the gold standard for treating dysmenorrhea because they target the biochemical cause of the pain. By lowering prostaglandin concentrations in the menstrual fluid, they reduce uterine hypercontractility. This provides significant relief for most patients.

Neonatal respiratory distress syndrome occurs due to surfactant deficiency and high alveolar surface tension. Clinical presentation involves compensatory mechanisms like expiratory grunting and intercostal pull to maintain functional residual capacity. Failure to stabilize leads to hypoxemia and acidosis.

A. Grunting: This audible expiratory sound results from the glottis closing against a partially expired breath to increase end-expiratory pressure. It prevents alveolar collapse in infants with decreased lung compliance. This finding is a hallmark sign of increased work of breathing.

B. Nasal flaring: Involuntary widening of the nostrils reduces upper airway resistance and increases the tidal volume during inspiration. It is an early physical manifestation of respiratory effort in newborns. This reflex helps maximize oxygen intake during physiological stress.

C. Cyanosis around mouth: Perioral blue discoloration, or circumoral cyanosis, is often a benign finding related to peripheral vasomotor instability in the first 24 hours. While central cyanosis is critical, perioral changes alone are less indicative of true respiratory failure.

D. Strong cry: A vigorous, loud cry indicates adequate vital capacity and neurological integrity in the neonatal period. It suggests the infant is capable of effective gas exchange and has sufficient muscular strength. This finding contradicts a diagnosis of acute distress.

E. Retractions: Visible sinking of the soft tissues around the ribs and sternum occurs when negative intrathoracic pressure is excessively high. It signifies the use of accessory muscles to overcome stiff, non-compliant lungs. Significant retractions indicate a high risk for exhaustion.